DHC · Diversified Healthcare Trust
$7.62
-0.12 (-1.49%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$1.91B
Shares
242.13M
Volume · Oct 5
233.89K
Avg daily vol (3M)
1.71M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.73
Open$7.86
Day$7.69–7.95
52W close$4.05–9.64
Avg vol 30d1.8M
Short int13.4M · 5.5% float · 8.4d
Short vol55%
Last earningsAug 4, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 3
Up next
Next earnings call
Nov 3, 2026
Est · unconfirmed
· in 4 wks
filed Aug 3, 2026
call held Aug 4, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.50B
Trailing 12 months
Net income (TTM)
−$265.95M
Trailing 12 months
Revenue growth YoY
-4.5%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.3%
Year over year · more shares
Price change (1Y)
+76.1%
Trailing year
Short interest
5.5%
Latest settlement · 8.4 days to cover
AI Brief
Q2 FY26 earnings call · Aug 4, 2026
Q2 FY26
TL;DR. DHC reported strong Q2 results with 37.2% YoY same-property SHOP NOI growth and reaffirmed recently raised full-year guidance, while reducing 2026 SHOP occupancy and revenue growth assumptions (offset by improved expense control) and announcing new operator contracts set to begin January 2027.
Bullish
- + Same-property SHOP NOI grew 37.2% YoY to $52 million with margins expanding 390 bps to 17.3%.
- + Medical office leasing was robust with 477,000 sq ft at 6.7% rent roll-up and 7.1-year weighted average lease term.
- + Full-year 2026 guidance was reaffirmed at raised levels, with SHOP NOI tracking toward high end.
Bearish
- − SHOP top-line pacing below initial 2026 projections with occupancy gains slower than expected.
- − Q2 shop same-store NOI included a ~$1.5 million one-time expense benefit not expected to repeat.
- − Three known MOB/life science tenant vacates representing ~4.6% of segment annualized revenue, with two effective July 1.
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Moderate
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+3%
above
Price vs 50-day avg
−5%
below
RSI (14)
40
neutral
MACD trend
Positive
52-week position
66%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+8%
trailing
YTD return
+59%
this year
Relative strength
−4%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $8 — 50d above 200d
Institutional flow
Flat
1 of 241 funds reported for Sep 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.54% of float · ▲ +3.8% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
241 holders — near 3-yr high, broad support
Squeeze score
56
elevated · 0–100
Fundamentals
Revenue growth
+2%
Y/Y
EPS growth
+23%
Y/Y
Balance sheet
$2.3B
net debt
Quant / Vol
risk profile
Volatility
38%
annualized · 1-yr
Max drawdown
−22%
past year
ATR
3.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 30, 2026
full-year 2026
Total NOI
Initiated
$307M – $323M
SHOP NOI
Initiated
$185M – $195M
Adjusted EBITDAre
Non-GAAP
Initiated
$300M – $315M
Normalized FFO per share
Non-GAAP
Initiated
$0.56 – $0.62
full year
Normalized FFO
Non-GAAP
$0.56 – $0.62
Adjusted EBITDA RE
Non-GAAP
$300M – $315M
SHOP revenue growth
6.6%
Average monthly rate growth
5.5%
SHOP operating expense growth
2.5%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+3%
Bullish
Price vs 50-day avg
−5%
Bearish
RSI (14)
40
Neutral
MACD trend
Positive
Bullish
52-week position
66%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $8 › 200d $8 — 50d above 200d
Institutional flow
Flat
1 of 241 funds reported for Sep 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.54% of float · ▲ +3.8% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
241 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $4
Now $8 · 66%
Range high $10
vs 200-day avg +3%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DHC
this stock
Diversified Healthcare Trust
|
$1.91B | +59.4% | +1.6% | — | 5.5% |
|
WELL
Welltower Inc.
|
$163.33B | +22.7% | +35.6% | 115.1 | 2.5% |
|
VTR
Ventas, Inc.
|
$44.42B | +8.6% | +18.5% | 160.4 | 3.9% |
|
OHI
Omega Healthcare Investors Inc
|
$14.02B | +3.1% | +13.2% | 16.5 | 4.8% |
|
DOC
Healthpeak Properties, Inc.
|
$13.61B | +21.2% | +4.5% | 56.4 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DHC | -4.9% | +0.8% | +8.3% | -1.5% | +59.4% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -4.7% | +1.2% | -3.9% | -2.5% | +46.5% |